Skip to main content

Now Qatar Investment Authority in talks with RIL to invest $1.5 billion in JioFiber: Report

After raising as much as $20 billion from foreign investors for RIL's digital services company Jio Platforms, the Mukesh Ambani-led company is now looking to sell stake in Jio Fibre Ltd

 

KEY HIGHLIGHTS

·         Sovereign wealth fund Qatar Investment Authority in talks to invest $1.5-2 billion on Jio Fiber

·         QIA will in infrastructure investment trust (InvIT) that holds the RIL's fibre optics business - Jio Fibre Pvt Ltd

 

KEY HIGHLIGHTS

  • · Sovereign wealth fund Qatar Investment Authority in talks to invest $1.5-2 billion on Jio Fiber
  • · QIA will in infrastructure investment trust (InvIT) that holds the RIL's fibre optics business - Jio Fibre Pvt Ltd

 

Mumbai: Doha-based sovereign wealth fund Qatar Investment Authority (QIA) is looking to invest $1.5 billion (Rs 11,200 crore) in Reliance Industries Ltd’s (RIL’s) Jio Fiber, said reports.

QIA is in advanced talks with RIL and will invest the sum in the infrastructure investment trust (InvIT) that holds the latter’s fibre optics business, as per a report in business daily Mint. 

After raising as much as $20 billion from foreign investors so far this year for the oil-to-telecom conglomerate’s digital services company, Jio Platforms, the Mukesh Ambani-led company is now looking to monetise its fibre optic assets in Jio Fibre Pvt Ltd.

The potential deal fits right in Reliance’s plans to make Jio an asset-light digital services company in order to keep costs minimum as the company prepares for a 5G launch across India, one of them, the report said quoting sources.

RIL has reportedly hired Citigroup Global Markets, Moelis and Co. and ICICI Securities as investment bankers for the potential stake sale in Jio Fiber. The proposed deal with QIA is one in a series of such deals announced by Reliance Industries as it tries to reinvent the company primarily as consumer tech and diversify from its credentials of being an oil and gas giant. 

Jio has so far raised over Rs 1.52 lakh crore from investors including Facebook, Google, Silver Lake Partners, Vista Equity Partners, General Atlantic, KKR, Mubadala, ADIA, TPG, L Catterton, PIF, Intel.


Global search engine giant Google was the latest to announce that it will invest Rs 33,737 crore into Jio Platforms for 7.73% stake in the latter. 

The investment valued RIL’s digital arm at an equity value of Rs 4.36 lakh crore. During RIL’s 43rd Annual General Meeting earlier his Ambani also announced that Jio Platforms and Google entered into a commercial agreement to jointly develop an entry-level affordable smartphone with optimizations to the Android operating system and the Play Store. 

The stock price of RIL has grown 2.4 times to date since hitting a low of Rs 867.43on March 23 as the company became debt free by raising money through a string of deals in Jio Platforms.


Source- timesnownews.com

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more